🔎 Trials Near Me

Hjem › Lungekreft › Florida › Orlando

Kliniske studier for Lungekreft i Orlando, FL

21 studier for Lungekreft søker deltakere på steder i og rundt Orlando (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RekruttererFase 1/2
  • Advent Health, Orlando
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

RekruttererFase 1/2
  • Clermont Oncology Center ( Site 0041), Clermont · 24 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07286149

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

RekruttererFase 2
  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

RekruttererFase 3
  • AdventHealth Cancer Institute, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06765109

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

RekruttererFase 3
  • Florida Cancer Specialists, Orlando
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • og 4 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07222566

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

RekruttererFase 2/3
  • Clermont Oncology Center, Clermont · 24 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06712316

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

RekruttererFase 1
  • Sarah Cannon Research Institute - Lake Nona Florida, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06293898

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RekruttererFase 3
  • Orlando Health Cancer Institute, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

RekruttererFase 1/2
  • Avenzo Therapeutics Recruiting Site, Orlando
Alder 18 til 75 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07038343

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

RekruttererFase 3
  • Orlando Health Cancer Center, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT07499674

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

RekruttererFase 3
  • Orlando Health Cancer Institute, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05624996

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

RekruttererFase 1/2
  • AdventHealth Celebration, Celebration · 17 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05592626

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

RekruttererFase 1/2
  • Clermont Oncology Center, Clermont · 24 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jul. 2026 · NCT04198766

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

RekruttererFase 1/2
  • Orlando Health Cancer Institute (Melanoma/NSCLC), Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 16. jul. 2026 · NCT06060613

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

RekruttererFase 1/2
  • Orlando Health Cancer Institute, Orlando
Alder 18 til 70 · Alle kjønn · Oppdatert 11. jun. 2026 · NCT05361174

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

RekruttererFase 1
  • Research Site, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT06835569

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

RekruttererFase 1
  • AdventHealth Cancer Institute, Celebration · 17 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 20. mar. 2026 · NCT05948865

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

RekruttererFase 1
  • Florida Cancer Specialists & Research Institute, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jan. 2026 · NCT07181473

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Adventhealth, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 17. nov. 2025 · NCT07231159

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

RekruttererObservasjonsstudie
  • Charter Research, Winter Park · 5 mi unna
  • I.H.S Health, LLC, Kissimmee · 16 mi unna
Alder 50 og eldre · Alle kjønn · Oppdatert 5. aug. 2025 · NCT06122077

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

RekruttererObservasjonsstudie
  • Orlando VA Healthcare System, Orlando
Alder 29 til 85 · Alle kjønn · Oppdatert 13. nov. 2024 · NCT06426628

Lungekreft-studier i andre byer

Andre studier i Orlando

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.